Literature DB >> 945123

Importance of mammary gland DNA synthesis on carcinogen-induced mammary tumorigenesis in rats.

H Nagasawa, R Yanai, H Taniguchi.   

Abstract

DNA synthesis in mammary gland estimated by [3H]thymidine incorporation was significantly higher on the day of proestrus than on the second day of diestrus in 50-day-old female Sprague-Dawley rats. The percentage of progressive mammary tumors, tumor growth rate, and the number and the weight of tumors per tumor-bearing rat were significantly higher in the animals given a single i.v. injection of 5 mg 7,12-dimethylbenz(a)anthracene at proestrus than in the animals given it at diestrus. Inhibition of DNA synthesis at proestrus by 2-bromo-alpha-ergocryptine also suppressed mammary tumorigenesis by the carcinogen. In 90-day-old rats in which little difference was found in mammary gland DNA synthesis between proestrus and diestrus, there was no difference in mammary tumorigenesis between animals given the carcinogen at proestrus and animals given it at diestrus. On the other hand, the prestimulation of mammary gland DNA synthesis by prolactin increased the growth, the number, and the weight of carcinogen-induced mammary tumors. These results demonstrate the importance of mammary DNA synthesis at the time when a carcinogen acts on the glands in mammary tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 945123

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Synergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatment.

Authors:  Paul W Sylvester
Journal:  Genes Nutr       Date:  2011-05-01       Impact factor: 5.523

2.  Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.

Authors:  J Russo; G Wilgus; I H Russo
Journal:  Am J Pathol       Date:  1979-09       Impact factor: 4.307

Review 3.  Timing of exposure and mammary cancer risk.

Authors:  Coral A Lamartiniere
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

4.  Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol.

Authors:  I H Russo; J Frederick; J Russo
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

5.  The effects of neonatal androgenization on mammary gland mitotic rate and susceptibility of carcinogen-induced mammary dysplastigenesis and tumorigenesis in LEW/Mai rats.

Authors:  D M Purnell
Journal:  Am J Pathol       Date:  1980-05       Impact factor: 4.307

6.  The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: a reappraisal.

Authors:  C W Welsch; M Goodrich-Smith; C K Brown; L Roth
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

7.  Exposure, susceptibility, and breast cancer risk: a hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence.

Authors:  N Krieger
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

Review 8.  Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.

Authors:  S Nandi; R C Guzman; J Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

9.  Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma.

Authors:  J Russo; L Tait; I H Russo
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

10.  Nonrandom frequency distribution of mitoses in rat lobuloaveolar mammary gland epithelium.

Authors:  D M Purnell; D J Stowers
Journal:  Am J Pathol       Date:  1977-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.